The document discusses different market segments for pet food products, including Wholesome Natural, Engineered, Private Label, and Therapeutic (Rx) brands. It highlights the differences in ingredients and regulatory requirements for these segments, particularly focusing on the use of grain proteins and the role of the FDA in regulating Therapeutic pet foods.
doj/DataSet10/EFTA01381253.pdf
{"document_type":"legal","document_subtype":"Form S-1","key_organizations":["U.S. Food and Drug Administration"],"reference_numbers":["DB-SDNY-0080084","SDNY_GM_00226268","EFTA01381253"]}